Blog

//Blog

NeuroDerm Achieves Primary Endpoint in ND0612H Phase II Trial for Advanced Parkinson’s Disease; Seeks Broader EU Label Based on iNDiGO Trial Following EMA Meeting

- Trial 006 demonstrated a statistically significant and clinically meaningful reduction in OFF-time and increase in proportion of patients “ON” by 8:00 am (primary and key secondary endpoints) - - The trial also showed statistically significant reduction in troublesome dyskinesia and a complete reduction of OFF-time to zero hours in 66% of responders (post hoc [...]

By |2018-11-20T08:53:30+00:00March 6th, 2017|Blog|Comments Off on NeuroDerm Achieves Primary Endpoint in ND0612H Phase II Trial for Advanced Parkinson’s Disease; Seeks Broader EU Label Based on iNDiGO Trial Following EMA Meeting

Gamida #Cell Announces First Patient #Transplanted in Phase 3 Registration Study of NiCord for #Blood #Cancers

JERUSALEM, Feb. 28, 2017 /PRNewswire/ -- Gamida Cell, a leader in cellular and immune therapies for the treatment of cancer and orphan genetic diseases, announced today that the first patient has been transplanted in the Company's Phase 3 study of NiCord®, in development as a cure for patients with blood cancer who do not have [...]

By |2018-11-20T08:54:16+00:00March 6th, 2017|Blog|Comments Off on Gamida #Cell Announces First Patient #Transplanted in Phase 3 Registration Study of NiCord for #Blood #Cancers

#Biomed2017 – XACT Robotics raises $5m

10 Aug, 2015 15:07 Gali Weinreb The Israeli company will use the investment to fund US trials for its needle steering technology. XACT Robotics, an Israeli startup developing novel platform robotic technology for use in minimally invasive procedures has raised $5 million. The latest round of funding was led by MEDX Ventures Group, which founded [...]

By |2018-11-20T08:54:23+00:00March 5th, 2017|Blog|Comments Off on #Biomed2017 – XACT Robotics raises $5m

Medisafe Takes In $14.5M to Help Patients Manage Medications

Prescriptions can be complicated and confusing, especially for patients taking more than one set of pills. But when people don’t properly follow their prescription plans, it can lead to deteriorating health, additional hospital visits, and potentially life-threatening episodes. The costs are high for the healthcare industry, too. Studies have estimated that more than $100 billion [...]

By |2018-11-20T08:54:38+00:00March 5th, 2017|Blog|Comments Off on Medisafe Takes In $14.5M to Help Patients Manage Medications

Pharma Two B raises $30M for Parkinson’s phase 3 from Biogen-backed fund, adds ex-Pfizer CEO to board

by Nick Paul Taylor | Feb 27, 2017 7:34am Pharma Two B will run a phase 3 of its pramipexole-rasagiline fixed-dose combination P2B001. Pharma Two B has raised $30 million (€28 million) to complete a phase 3 trial of its Parkinson’s asset P2B001. The round provides a hint of the impact of the recently founded [...]

By |2018-11-20T08:54:48+00:00February 28th, 2017|Blog|Comments Off on Pharma Two B raises $30M for Parkinson’s phase 3 from Biogen-backed fund, adds ex-Pfizer CEO to board

7 disruptive innovations from medical device suppliers

Medical device innovation doesn’t just come from small, single-product startups – contract manufacturers are increasingly a part of developing truly disruptive medtech.  Chris Newmarker, Managing Editor   People sometimes make the mistake of viewing innovation as the product of a few geniuses and mavericks. But in fact, it is often the result of teamwork, as the [...]

By |2018-11-20T08:55:03+00:00February 28th, 2017|Blog|Comments Off on 7 disruptive innovations from medical device suppliers

Medtech Insight’s weekly podcast on Biomed Israel and Israeli medical devices & digital health companies

Listen to Medtech Insight's podcast on selected Israeli medical device & digital health companies that was broadcast this week. On this week's Medtech Insight podcast: the response by a US FDA advisory panel to Claret Medical's de novo submission for the first brain-filter device intended to protect patients undergoing transcatheter aortic heart valve replacement; a [...]

By |2018-11-20T08:55:10+00:00February 27th, 2017|Blog|Comments Off on Medtech Insight’s weekly podcast on Biomed Israel and Israeli medical devices & digital health companies

Genetically engineered T-cells treat leukemia in babies

Genetically engineered T-cells treat leukemia in babies February 16, 2017 By Danielle Kirsh Researchers in London have successfully treated leukemia in two babies, in what they are touting as the world’s first treatment of cancer using genetically engineered immune cells from donors.Doctors treated two British infants, 11 and 16 months old, using Cellectis’s CAR T-cell [...]

By |2018-11-20T08:55:21+00:00February 27th, 2017|Blog|Comments Off on Genetically engineered T-cells treat leukemia in babies

MindUP incubator takes in first startup

Hemonitor measures blood flow in the main artery of intensive care patients. The MindUP technology incubator, a partnership between Pitango Venture Capital, the Rambam Health Care Campus, medical device company Medtronic, IBM, and the Impact First investment fund, has accepted its first company - Hemonitor.Hemonitor measures blood flow in the main artery of patients arriving [...]

By |2018-11-20T08:55:36+00:00February 27th, 2017|Blog|Comments Off on MindUP incubator takes in first startup

Intensix Data Analytics Demo High Accuracy In ICU Sepsis Detection

Catherine Longworth@MedtechCate catherine.longworth@informa.com Executive Summary An analytics platform developed by Israeli big data company Intensix has shown high accuracy for detecting and predicting sepsis in critical care. The positive results were presented at the Healthcare Information and Management Systems Society (HIMSS) healthcare IT conference in Orlando, Florida. A new study has shown that an analytics [...]

By |2018-11-20T08:55:48+00:00February 27th, 2017|Blog|Comments Off on Intensix Data Analytics Demo High Accuracy In ICU Sepsis Detection